Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-018909·Invus Global Management, LLC
Schedule 13G ownership disclosure
Solid Biosciences Inc
Common Stock, $0.001 par value per share · CUSIP: 83422E204
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Invus Public Equities, L.P.
Shares: 3,265,927 · Class: 8.2%
- Invus Public Equities Advisors, LLC
Shares: 3,265,927 · Class: 8.2%
- Invus Global Management, LLC
Shares: 3,265,927 · Class: 8.2%
- Siren, L.L.C.
Shares: 3,265,927 · Class: 8.2%
- Avicenna Life Sci Master Fund LP
Shares: 483,114 · Class: 1.2%
- Avicenna Life Sci Master GP LLC
Shares: 483,114 · Class: 1.2%
- Ulys, L.L.C.
Shares: 483,114 · Class: 1.2%
- Raymond Debbane
Shares: 3,749,041 · Class: 9.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-018909
- Form type
- SCHEDULE 13G/A
- Filer
- Invus Global Management, LLC
- CIK
- CIK 2005369
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership